Live Breaking News & Updates on Mark Wuttke

Stay updated with breaking news from Mark wuttke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Topline results show MyopiaX light stimulation safe, tolerable in children

Dopavision has announced positive topline results from a proof-of-concept trial of MyopiaX, a noninvasive photobiomodulation intervention designed to slow myopia progression in children.“The 6-month outcomes represent a significant step in the clinical development of MyopiaX,” Ian Flitcroft, PhD, FRCOphth, coordinating investigator of the MyopiaX-1 trial, said in a company press ....

Heather Biele , Ian Flitcroft , Mark Wuttke ,

Dopavision Announces Topline Results in Clinical Trial of Targeted Photobiomodulation Approach for Progressive Myopia

Safe and Tolerable: MyopiaX-1 proof-of-concept clinical trial (NCT04967287) supports MyopiaX's excellent safety and tolerability profile with no untoward safety events. Novel Approach: Dopavision's ....

Novartis Pharma , Dopavision Gmb , Ian Flitcroft , Mark Wuttke , Ababax Health , Boehringer Ingelheim Venture Fund , German Federal Ministry Of Education , Business Wire , Coordinating Investigator , With Myopiax , Seventure Partners , German Federal Ministry , Executive Officer , Ihr Portfolio ,

Dopavision Reports Successful Completion of Enrollment for MyopiaX-1 Trial

- MyopiaX-1 trial to generate first clinical evidence with MyopiaX®,a novel therapeutic approach to manage myopia progression ....

City Of , United Kingdom , Comunidad Autonoma De Cataluna , Ludger Wess Ines Regina Buth , Novartis Pharma , Dopavision Gmb , Makula Netzhaut Zentrum Breyer Kaymak , Mark Wuttke , German Federal Ministry Of Education , Centre For Eye Research Dublin , Johannes Gutenberg University , Boehringer Ingelheim Venture Fund , Erasmus University Medical Center , University Eye Hospital , University Of Minho , Technological University Dublin , University Complutense , Ababax Health , University Medical Center , Data Safety Monitoring Board , Netzhaut Zentrum Breyer Kaymak , Eye Clinic , Medical Center , Sant Joan , Eye Research Dublin , Seventure Partners ,

Dopavision Reports Successful Completion of Enrollment for

- MyopiaX-1 trial to generate first clinical evidence with MyopiaX®, a novel therapeutic approach to manage myopia progression- First data readout expected. ....

United Kingdom , City Of , Comunidad Autonoma De Cataluna , Ludger Wess Ines Regina Buth , Makula Netzhaut Zentrum Breyer Kaymak , Novartis Pharma , Mark Wuttke , Dopavision Gmb , University Complutense , University Eye Hospital , Boehringer Ingelheim Venture Fund , German Federal Ministry Of Education , Johannes Gutenberg University , Ababax Health , University Of Minho , University Medical Center , Technological University Dublin , Centre For Eye Research Dublin , Erasmus University Medical Center , Data Safety Monitoring Board , Netzhaut Zentrum Breyer Kaymak , Eye Clinic , Medical Center , Sant Joan , Eye Research Dublin , Seventure Partners ,

Enrollment complete for study of MyopiaX app in children, adolescents

Enrollment complete for study of MyopiaX app in children, adolescents
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Heather Biele , Mark Wuttke ,